PYC Therapeutics Limited (ASX:PYC)

PYC Therapeutics Revenue

PYC Therapeutics had revenue of 11.84M AUD in the half year ending December 31, 2024, with 240.92% growth. This brings the company's revenue in the last twelve months to 24.99M, up 17.64% year-over-year. In the fiscal year ending June 30, 2024, PYC Therapeutics had annual revenue of 22.06M with 39.56% growth.

• Revenue (ttm): 24.99M
• Revenue Growth: +17.64%
• P/S Ratio: 26.46
• Revenue / Employee: 5.00M
• Employees: 5
• Market Cap: 661.14M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	22.06M	6.25M	39.56%
Jun 30, 2023	15.81M	-236.57K	-1.47%
Jun 30, 2022	16.04M	12.97M	421.83%
Jun 30, 2021	3.07M	678.66K	28.33%
Jun 30, 2020	2.40M	-	-